151 related articles for article (PubMed ID: 22716256)
1. Mouse Samd9l is not a functional paralogue of the human SAMD9, the gene mutated in normophosphataemic familial tumoral calcinosis.
Li Q; Guo H; Matsui H; Honda H; Inaba T; Sundberg JP; Sprecher E; Uitto J
Exp Dermatol; 2012 Jul; 21(7):554-6. PubMed ID: 22716256
[TBL] [Abstract][Full Text] [Related]
2. Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse.
Li CF; MacDonald JR; Wei RY; Ray J; Lau K; Kandel C; Koffman R; Bell S; Scherer SW; Alman BA
BMC Genomics; 2007 Apr; 8():92. PubMed ID: 17407603
[TBL] [Abstract][Full Text] [Related]
3. Evolution and divergence of the mammalian SAMD9/SAMD9L gene family.
Lemos de Matos A; Liu J; McFadden G; Esteves PJ
BMC Evol Biol; 2013 Jun; 13():121. PubMed ID: 23758988
[TBL] [Abstract][Full Text] [Related]
4. The Samd9L gene: transcriptional regulation and tissue-specific expression in mouse development.
Jiang Q; Quaynor B; Sun A; Li Q; Matsui H; Honda H; Inaba T; Sprecher E; Uitto J
J Invest Dermatol; 2011 Jul; 131(7):1428-34. PubMed ID: 21412262
[TBL] [Abstract][Full Text] [Related]
5. A paralogous pair of mammalian host restriction factors form a critical host barrier against poxvirus infection.
Meng X; Zhang F; Yan B; Si C; Honda H; Nagamachi A; Sun LZ; Xiang Y
PLoS Pathog; 2018 Feb; 14(2):e1006884. PubMed ID: 29447249
[TBL] [Abstract][Full Text] [Related]
6. Identification of CP77 as the Third Orthopoxvirus SAMD9 and SAMD9L Inhibitor with Unique Specificity for a Rodent SAMD9L.
Zhang F; Meng X; Townsend MB; Satheshkumar PS; Xiang Y
J Virol; 2019 Jun; 93(12):. PubMed ID: 30918078
[TBL] [Abstract][Full Text] [Related]
7. Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome.
Cammenga J
Exp Hematol; 2024 Jun; 134():104217. PubMed ID: 38649131
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L Mutations.
Ahmed IA; Farooqi MS; Vander Lugt MT; Boklan J; Rose M; Friehling ED; Triplett B; Lieuw K; Saldana BD; Smith CM; Schwartz JR; Goyal RK
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2186-2196. PubMed ID: 31306780
[TBL] [Abstract][Full Text] [Related]
9. Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.
Thomas ME; Abdelhamed S; Hiltenbrand R; Schwartz JR; Sakurada SM; Walsh M; Song G; Ma J; Pruett-Miller SM; Klco JM
Leukemia; 2021 Nov; 35(11):3232-3244. PubMed ID: 33731850
[TBL] [Abstract][Full Text] [Related]
10. [Association between SAMD9/SAMD9L and hematological malignancies].
Narumi S; Hasegawa T
Rinsho Ketsueki; 2018; 59(11):2475-2480. PubMed ID: 30531146
[TBL] [Abstract][Full Text] [Related]
11. PARP14 correlates with GBM proliferation and poor prognosis by elevating expression of SAMD/SAMD9L.
Zhang L; Chen W; Shi Z; Shang Z
Ir J Med Sci; 2024 Apr; 193(2):585-593. PubMed ID: 37612499
[TBL] [Abstract][Full Text] [Related]
12. Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7.
Nagamachi A; Matsui H; Asou H; Ozaki Y; Aki D; Kanai A; Takubo K; Suda T; Nakamura T; Wolff L; Honda H; Inaba T
Cancer Cell; 2013 Sep; 24(3):305-17. PubMed ID: 24029230
[TBL] [Abstract][Full Text] [Related]
13. Viral host range factors antagonize pathogenic SAMD9 and SAMD9L variants.
Gahr S; Perinetti Casoni G; Falk-Paulsen M; Maschkowitz G; Bryceson YT; Voss M
Exp Cell Res; 2023 Apr; 425(2):113541. PubMed ID: 36894052
[TBL] [Abstract][Full Text] [Related]
14. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.
Davidsson J; Puschmann A; Tedgård U; Bryder D; Nilsson L; Cammenga J
Leukemia; 2018 May; 32(5):1106-1115. PubMed ID: 29535429
[TBL] [Abstract][Full Text] [Related]
15. Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes.
Wong JC; Bryant V; Lamprecht T; Ma J; Walsh M; Schwartz J; Del Pilar Alzamora M; Mullighan CG; Loh ML; Ribeiro R; Downing JR; Carroll WL; Davis J; Gold S; Rogers PC; Israels S; Yanofsky R; Shannon K; Klco JM
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046003
[TBL] [Abstract][Full Text] [Related]
16. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS; Kozyra EJ; Wlodarski MW
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
[TBL] [Abstract][Full Text] [Related]
17. Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein.
Chefetz I; Ben Amitai D; Browning S; Skorecki K; Adir N; Thomas MG; Kogleck L; Topaz O; Indelman M; Uitto J; Richard G; Bradman N; Sprecher E
J Invest Dermatol; 2008 Jun; 128(6):1423-9. PubMed ID: 18094730
[TBL] [Abstract][Full Text] [Related]
18. A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis.
Topaz O; Indelman M; Chefetz I; Geiger D; Metzker A; Altschuler Y; Choder M; Bercovich D; Uitto J; Bergman R; Richard G; Sprecher E
Am J Hum Genet; 2006 Oct; 79(4):759-64. PubMed ID: 16960814
[TBL] [Abstract][Full Text] [Related]
19. Inflammation fuels bone marrow exhaustion caused by Samd9l mutation.
Jung M
J Clin Invest; 2022 Nov; 132(21):. PubMed ID: 36317635
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis.
Hershkovitz D; Gross Y; Nahum S; Yehezkel S; Sarig O; Uitto J; Sprecher E
J Invest Dermatol; 2011 Mar; 131(3):662-9. PubMed ID: 21160498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
